VEGFA and myocardial infarction: There was no significant difference between anti-VEGF and control in the risk of myocardial infarctions, with a risk ratio being 0.69 (0.40–1.21) by fixed-effects analysis and 0.70 (0.39 to 1.28) by random effects analysis (Figure 5).